MARZIO, Leonardo
 Distribuzione geografica
Continente #
NA - Nord America 6.510
EU - Europa 5.013
AS - Asia 4.632
SA - Sud America 561
AF - Africa 45
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 8
Totale 16.786
Nazione #
US - Stati Uniti d'America 6.420
SG - Singapore 1.636
CN - Cina 1.521
UA - Ucraina 974
IE - Irlanda 777
IT - Italia 715
TR - Turchia 697
SE - Svezia 641
GB - Regno Unito 581
BR - Brasile 468
FR - Francia 446
IN - India 404
DE - Germania 345
VN - Vietnam 211
FI - Finlandia 207
RU - Federazione Russa 142
PL - Polonia 60
CA - Canada 46
MX - Messico 32
AR - Argentina 30
KR - Corea 27
EC - Ecuador 25
BD - Bangladesh 21
IQ - Iraq 18
ZA - Sudafrica 18
BE - Belgio 17
EU - Europa 17
ID - Indonesia 15
RO - Romania 15
NL - Olanda 14
HK - Hong Kong 13
ES - Italia 12
JP - Giappone 12
CZ - Repubblica Ceca 11
LT - Lituania 11
PY - Paraguay 11
CO - Colombia 10
GR - Grecia 10
IL - Israele 10
AT - Austria 9
PK - Pakistan 9
AU - Australia 8
MA - Marocco 8
CL - Cile 6
DZ - Algeria 6
AL - Albania 5
IR - Iran 5
KE - Kenya 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
PE - Perù 4
PT - Portogallo 4
CH - Svizzera 3
GT - Guatemala 3
NO - Norvegia 3
NP - Nepal 3
PS - Palestinian Territory 3
SA - Arabia Saudita 3
TW - Taiwan 3
VE - Venezuela 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
JM - Giamaica 2
KZ - Kazakistan 2
MD - Moldavia 2
OM - Oman 2
SC - Seychelles 2
UZ - Uzbekistan 2
BY - Bielorussia 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IM - Isola di Man 1
JO - Giordania 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
MY - Malesia 1
PH - Filippine 1
SR - Suriname 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 16.786
Città #
Singapore 1.095
Jacksonville 1.078
Chandler 779
Dublin 764
Dearborn 458
Southend 422
Princeton 386
Dallas 335
Izmir 333
Nanjing 327
Beijing 315
Ashburn 258
Wilmington 257
Los Angeles 192
Cambridge 181
Tongling 135
Buffalo 123
Woodbridge 118
Ann Arbor 113
The Dalles 110
Nanchang 104
Santa Clara 104
New York 98
Ho Chi Minh City 78
Boardman 65
Houston 65
Council Bluffs 64
Shenyang 62
Hebei 56
Altamura 54
Munich 50
Kunming 49
Hefei 48
Rome 47
São Paulo 47
Tianjin 46
Jiaxing 44
Kraków 36
Redondo Beach 36
Chieti 35
Hangzhou 31
Hanoi 30
Jinan 26
Bologna 25
Milan 24
Norwalk 24
Grevenbroich 22
London 21
Brooklyn 20
Dong Ket 20
Guangzhou 20
Orange 20
Warsaw 20
Changsha 19
Seoul 19
Boston 18
Helsinki 17
Washington 17
Brussels 16
Guayaquil 16
Rio de Janeiro 16
Düsseldorf 15
Stockholm 15
Augusta 14
Brasília 14
Denver 14
Turku 14
Vinh 14
Belo Horizonte 13
Hong Kong 13
Changchun 12
Chennai 12
Johannesburg 12
Lanzhou 12
Seattle 12
Charlotte 11
Chicago 11
Frankfurt am Main 11
Pescara 11
San Francisco 11
San Mateo 11
Tokyo 11
Toronto 11
Ningbo 10
Baghdad 9
Cepagatti 9
Curitiba 9
Fuzhou 9
Guadalajara 9
Moscow 9
Phoenix 9
Amsterdam 8
Ankara 8
Brno 8
Da Nang 8
Haiphong 8
L'aquila 8
Montreal 8
Nuremberg 8
Zhengzhou 8
Totale 9.827
Nome #
Il tempo di transito oro-cecale (TTOC) è accelerato dopo somministrazione orale di allergene alimentare nei pazienti con sindrome del colon irritabile (SCI) e prick test positivo 386
EFFICACY OF TREATMENT WITH PYLERA IN COMBINATION WITH RANITIDINE ON FIRST-LINE INFECTION HELICOBACTER PYLORI: EXPERIENCE OF A SINGLE CENTER 184
A Triple and Quadruple Therapy with Doxycycline and Bismuth for First-Line Treatment of Helicobacter pylori Infection: A Pilot Study 163
48-Hour continuous pH measurement in patients with gastro-oesophageal reflux: effect of cisapride. 144
24-hour pancolonic motility using a portable electronic probe in healthy subjects 142
SYMPTOM PATTERN IN FUNCTIONAL DYSPEPSIA AND GASTROESOPHAGEAL REFLUX DISEASE: ROLE OF H. PYLORI INFECTION 142
Analysis of genetic variability, antimicrobial susceptibility and virulence markers in Helicobacter pylori identified in Central Italy. 141
Beneficial effects of SR140333, a novel substance P antagonist, in a rat model of experimental colitis 140
In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy 140
Antibacterial effect of plant extracts against Helicobacter pylori 140
Detection of Helicobacter pylori in the gastrointestinal tract of Balb/C euthymic mice infected by human Helicobacter pylori and evidence for transmission 134
Bovine lactoferrin enhances the efficacy of levofloxacin-based triple therapy as first-line treatment of Helicobacter pylori infection: an in vitro and in vivo study. 133
Anti-Helicobacter pylori specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimen from patients treated with triple therapy.Am. J. Gastroenterol 130
SR140333, a substance P receptor antagonist, influences morphological and motor changes in rat experimental colitis 130
Two weeks regimen with amoxillicin, tinidazole and omeprazole eradicates helicobacter pylori and cures active duodenal ulcer 129
Correlation between anal canal size and anal canal pressure: an ultrasonografhip and manometric study 127
Circadian variations in antioxidant defences and lipid peroxidation in the rat heart 126
Helicobacter pylori isolates from proximal and distal stomach of patients never treated and already treated show genetic variability and discordant antibiotic resistance. 126
Trasmissione di Helicobacter pylori in un modello murino 124
Anti-H pylori specific antibody immunoistochemistry improves the diagnostic accuracy of H piylori in biopsy specimen from patients treated with triple therapy 123
Coccoid Helicobacter pylori not culturable in vitro reverts in mice. 123
Anal canal diameters and pessure measured simultaneously by real time ultrasonography and manometry in human subjects 121
Diameters and pressures of the anal canal simultaneously measured with endosonography and manometry 120
Uso razionale di schemi terapeutici nelle infezioni da Helicobacter pylori 119
FUSOBACTERIUM NUCLEATUM (FN) IN PATIENTS AFFECTED BY INFLAMMATORY BOWEL DISEASE 118
Cigarette smoke, ferritin, and lipid peroxidation 117
Alterazioni contrattili della muscolatura liscia nel corso di colite sperimentale sono ridotte da un antagonista specifico della sostanza P 117
Heightened free radical activity in angina pectoris 116
Treatment of Helicobacter pylori (Hp) infection with an association of Omeprazole and Roxytromicine: a study in vivo and in vitro. 116
L'eritromicina accelera lo svuotamento gastrico e colecistico nell'uomo attraverso un meccanismo mediato dall'acetilcolina 116
THE INFLUENCE OF ACID REFLUX ON THE HEART RATE VARIABILITY (HRV) IN PATIENTS WITH AND WITHOUT GASTROESOPHAGEAL REFLUX DISEASE (GERD) 114
COMBINED VIDEOCAPSULE ENDOSCOPY (VCE) AND LACTULOSE HYDROGEN BREATH TEST (LHBT): A COMPARATIVE STUDY TO ASSESS ORO-CECAL TRANSIT TIME (OCTT). 114
Detection of Helicobacter pylori in saliva and esophagus 113
Blood cardioplegia reduces oxidant burden in the ischemic and reperfused human myocardium 113
Aortic glutathione-related antioxidant defences in rabbits subjected to suprarenal aortic coarctation hypertension 111
THE INFLUENCE OF ACID REFLUX ON THE HEART RATE VARIABILITY (HRV) IN PATIENTS WITH AND WITHOUT GASTROESOPHAGEAL REFLUX DISEASE (GERD). 111
Effect of ischemia and reperfusion on antioxidant enzymes and mitochondrial inner membrane proteins in perfused rat heart. 110
Heparin: does it act as an antioxidant in vivo? 110
ESOPHAGITIS AND ITS CAUSES: WHO IS "GUILTY" WHEN ACID IS FOUND "NOT GUILTY"? 110
[Physiopathological bases of the medical treatment of portal hypertension]. 109
Morphological and motor changes during experimental colits in rats are prevented by a specific substance p antagonist 109
Rifabutin based triple therapy for eradication of H.pylori primary and secondary resistant to tinidazole and clarithromycin 108
Detection of Helicobacter pylori in esophagus and saliva in humans 108
Pharyngeal, Esophageal and Gastric Motility in Normal Subjects and in patients with gastroesophageal Reflux Disease 107
Triple therapy for 7 days plus omeprazole for 21 days in treatment of active duodenal ulcer with Helicobacte pylori infection. A double blind placebo controlled trial. 107
Short- and long-term omeplazole for the tratment and prevention of duodenal ulcer, and effect on helicobacter pylori 106
EVALUATION OF INTRAPARENCHYMAL AND PORTAL BLOOD FLOW BY CONTRAST ENHANCED ULTRASOUND (CEUS) AND LIVER STIFFNESS BY FIBROSCAN IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CHRONIC HEPATITIS C (CHC) 106
Swallows, oesophageal and gastric motility in normal subjects and in patients with gastro-oesophageal reflux disease: a 24-h-pH-manometric study 105
5-HT1-RECEPTOR AGONIST SUMATRIPTAN MODIFIES GASTRIC SIZE AFTER 500 ML OF WATER IN DYSPEPTIC PATIENTS AND NORMAL SUBJECTS 105
PRUCALOPRIDE ACCELERATES GASTRIC AND SMALL BOWEL TRANSIT TIMES OF VIDEOCAPSULES ENDOSCOPY 105
MIGRATING MOTOR COMPLEX RECORDED SPONTANEOUSLY AND INDUCED BY MOTILIN AND ERYTHROMYCIN IN AN EX VIVO RABBIT INTESTINAL PREPARATION 104
CAN HELICOBACTER PYLORI INFECTION HAVE A ROLE ON CLINICAL APPEARANCE OF GERD? 104
EVALUATION OF INTRAPARENCHYMAL AND PORTAL BLOOD FLOW BY CONTRAST ENHANCED ULTRASOUND (CEUS) AND LIVER STIFFNESS BY FIBROSCAN IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CHRONIC HEPATITIS C (CHC). 103
Effects of cimetropium bromide on gallbladder contraction in response to oral and intraduodenal olive oil. 103
Gastric antral and fundus receptive relaxation in dyspeptic patients and normal subjects 102
EFFECT OF CIMETROPIUM BROMIDE ON GALLBLADDER CONTRACTION IN RESPONSE TO ORAL AND INTRADUODENAL OLIVE OIL 101
H2-RECEPTOR ANTAGONISTS ARE SCAVENGERS OF OXYGEN RADICALS 101
Masse all'ipocondrio dx e carcinoma della colecisti 101
Esophageal and gastric motility in patients with gastroesophageal reflux disease 100
EVALUATION OF LIVER BLOOD FLOW AND FIBROSIS IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CIRRHOSIS IN COMPARISON WITH NORMAL CONTROLS THROUGH CONTRAST ENHANCED ULTRASOUND(CEUS) AND FIBROSCAN 100
SHORT AND LONG TERM EFFICACY OF GLYCERYL TRINITRATE (GTN) OINTMENT 0.2% AND 2% ON ANAL CANAL PRESSURE IN PATIENTS WITH CHRONIC ANAL FISSURES. 99
Erythromycin accellerates gastric and gallbladder emptying through a cholinergic mediated mechanism in humans 99
TYPICAL AND ATYPICAL SYMPTOMS OF GASTRO ESOPHAGEAL REFLUX DISEASE: DOES Helicobacter pylori MATTER? 99
Effect of glyceryl trinitrate ointment (GTO) 0.2% and 2% on anal canal pressure during acute and chronic application in patients with anal fissure 98
Effects of combining extracts (from Propolis or Zingiber officinale) with Clarithromycin on H.pylori. 98
Identification of a novel mutation affecting domain V of the 23S rRNA gene in Helicobacter pylori 98
TRANSIENT LOWER ESOPHAGEAL SPHINCTER RELAXATIONS AND GASTRO-ESOPHAGEAL REFLUX EPISODES IN HEALTHY SUBJECTS AND GERD PATIENTS DURING 24 HOURS 98
Glutathione peroxidase, glutathione reductase and glutathione transferase activities in the human artery, vein and heart. 98
Oesophageal and gastric motility in patients with gastro-oesophageal reflux disease 97
Evidence for an oro-fecal transmission inan experimental murine model of helicobacter pylori infection. 97
Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication. 97
Effect of omeprazole, clarithromicin and amoxicillin for a short time on helicobacter pylori eradication 96
Role of transient lower esophageal sphincter relaxations in the genesis of priximal gastro-esophageal reflux 96
ESOPHAGEAL MOTILITY ASSESSMENT AFTER PRUCALOPRIDE ADMINISTRATION IN PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY (IEM) AND SYSTEMIC SCLEROSIS. 96
Distensione gastrica nei soggetti normali e nei pazienti dispeptici helicobacter pylori positivi e negativi e correlazione con i sintomi 94
Regional distribution of glutathione-related antioxidant defences in the normal rabbit aorta. 93
EFFICACIA E SICUREZZA DEL RITRATTAMENTO CON INFLIXIMAB IN UN PAZIENTE AFFETTO DA MORBO DI CROHN 93
Prolonged anal sphincter manometry in normal human subjects 92
GRAVIDANZA IN UNA PAZIENTE AFFETTA DA RETTOCOLITE ULCEROSA IN TERAPIA CON INFLIXIMAB: CASO CLINICO 92
Influence of physical activity on gastric emptying of liquids in normal human subjects 92
DISORDINI MOTORI ASPECIFICI DELL’ESOFAGO 92
EFFECT OF AN ACUTE INTRALUMINAL ADMINISTRATION OF CAPSAICIN ON OESOPHAGEAL MOTOR PATTERN IN GORD PATIENTS WITH INEFFECTIVE OESOPHAGAL MOTILITY 92
PRUCALOPRIDE INCREASES BASAL LES TONE IN PATIENTS WITH ESOPHAGEAL MOTILITY DISORDERS 92
Pylera® plus ranitidine vs Pylera® plus esomeprazole in first-line treatment of Helicobacter pylori infection: Two pilot studies 92
EFFECT OF THE 5-HT3 RECEPTOR ANTAGONIST, ONDANSETRON, ON GASTRIC SIZE IN DYSPEPTIC PATIENTS WITH IMPAIRED GASTRIC ACCOMODATION 91
SPONTANEOUS OPENING OF LES IN ACHALASIA: AN UNCOMMON ON-LINE DOCUMENTATION BY HIGH-RESOLUTION MANOMETRY 91
Registrazione delle 24 ore della motilità del piloro in soggetti normali 90
EFFECT OF CLEBOPRIDE ON ESOPHAGEAL MOTOR FUNCTION IN GERD PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY: EVALUATION USING HIGH RESOLUTION MANOMETRY 90
Changes in the myocardial enzymatic systems (AES) induced by ischemia-reperfusion in the isolated rat heart 90
Gastric antral and fundic distention evaluated by ultrasonography (US) in normal subjects and patients with idiopathic dyspepsia 89
Proximal and Distal Gastric Distension in Normal Subjects and H. pylori-Positive and -Negative Dyspeptic Patients and Correlation with Symptoms 89
LA MALDIGESTIONE 89
EFFECT OF THE 5-HT1 AGONIST SUMATRIPTAN ON ESOPHAGEAL MOTOR PATTERN IN PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY 88
Sodium cromoglycate in the treatment of eosinophilic gastroenteritis. 88
ULTRASOUND(US) GRADED HEPATOSTEATOSIS ASSESSMENT THROUGH CONTRAST ENHANCED ULTRASOUND (CEUS) AND FIBROSCAN IN NON ALCOHOLIC FATTY LIVER DISEASE 88
Proximal and Distal Gastric Distension in Normal Subjects and H.pylori-Positive and -Negative Dyspeptic Patients and Correlation with Symptoms 87
La terapia chirurgica laparoscopica della malattia da reflusso gastro-esofageo 87
EFFECT OF HYOSCINE N-BUTYLBROMIDE ON GASTROESOPHAGEAL REFLUX IN NORMAL SUBJECTS AND PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE. 87
Valore dell'ecotomografia nella diagnosi delle metastasi epatiche nei pazienti portatori di neoplasia gastrointestinale 87
ROLE OF PRUCALOPRIDE (RESOLOR) IN THE SETTING-UP OF PILLCAM COLON-CAPSULE ENDOSCOPY (CCE). EXPERIENCEFROM A SINGLE CENTRE 87
Totale 11.095
Categoria #
all - tutte 63.040
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.040


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021641 0 0 0 0 0 239 14 18 80 190 23 77
2021/2022794 28 12 6 200 75 9 10 65 55 6 89 239
2022/20232.220 199 234 122 268 186 514 150 160 259 29 54 45
2023/20241.019 77 52 65 29 33 313 252 40 3 41 17 97
2024/20252.642 189 410 308 38 65 67 48 161 335 110 279 632
2025/20262.650 466 278 668 697 468 73 0 0 0 0 0 0
Totale 17.044